William Blair believes investors could view Viking Therapeutics (VKTX)’ multi-year manufacturing pact with CordenPharma as a negative to Viking’s takeover prospects. Nonetheless, the analyst ...
Viking Therapeutics (VKTX) announced that it has signed a broad, multi-year manufacturing agreement with CordenPharma, a contract development and manufacturing organization, covering both the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback